首页|SCFβ-TrCP泛素化降解TFAP4抑制结直肠癌上皮间质转化的分子机制研究

SCFβ-TrCP泛素化降解TFAP4抑制结直肠癌上皮间质转化的分子机制研究

扫码查看
目的 探究 SCFβ-TrCP泛素化降解转录因子激活增强子结合蛋白 4(transcription factor-activated enhancer-binding protein 4,TFAP4)对结直肠癌上皮间质转化的影响.方法 体外培养人结肠腺癌细胞 SW480,分别用不同浓度的 MLN4924 处理24h,然后采用 Western blot法检测内源性 TFAP4 蛋白水平变化.在 MLN4924 处理的基础上,加入 CHX分别干预不同时间,检测TFAP4 的蛋白半衰期和泛素化水平差异.在 CHX 干预的 SW480 细胞中过表达带 FLAG 标签的 TrCP-1,探究 β-TrCP 对TFAP4 表达的影响,通过免疫共沉淀(co-immunoprecipitation,Co-IP)实验检测过表达或敲低 β-TrCP 不是因为影响了其他信号通路而改变TFAP4 的水平.将TFAP4 上 135 位的E突变为A,139 位的S突变为A,然后在CHX干预的SW480 细胞中转染结构域突变的 TFAP4,测定 TFAP4 半衰期和泛素化水平变化.CK1/CK2/GSK3 磷酸化关键酶抑制剂对 SW480 细胞进行干预,Western blot法检测TFAP4 水平,随后检测CK2 抑制剂对TFAP4 泛素化水平的影响,通过划痕实验分析细胞迁移能力,通过Tran-swell实验分析细胞侵袭能力.结果 TFAP4 随着 MLN4924 处理浓度变化呈剂量依赖式增加,MLN4924 处理能够显著延长内源TFAP4 蛋白的半衰期,TFAP4 和 CK2 存在相互作用,CK2 抑制剂能降低 TFAP4 泛素化水平,蛋白的半衰期得到明显延长,敲低β-TrCP引起 TFAP4 的降解受到明显抑制,β-TrCP与 TFAP4 直接相互作用,并促进其被泛素化,TFAP4 中 E135A 和 S139A 位点突变延长其半衰期,沉默 β-TrCP能促进细胞增殖和迁移.结论 SCFβ-TrCP可能通过泛素化修饰降解 TFAP4,从而抑制结直肠上皮间质转化的发生,进而抑制肿瘤的浸润、转移,可为结直肠癌治疗提供新的思路.
Molecular Mechanism of SCFβ-TrCP Ubiquitination and Degradation of TFAP4 to Inhibit Epithelial-mesenchymal Transition in Colorectal Cancer
Objective To explore the effect of SCFβ-TrCP ubiquitination and degradation of transcription factor-activated enhancer-binding protein 4(TFAP4)on epithelial-mesenchymal transformation in colorectal cancer.Methods Human colorectal adenocarcinoma cells SW480 were cultured in vitro and treated with different concentrations of MLN4924 for 24h,and then Western blot assay was used to detect the changes of endogenous TFAP4 protein levels.On the basis of MLN4924 treatment,CHX was added to intervene at different times to detect the difference of TFAP4 protein half-life time and ubiquitination level.Flag-labeled TrCP-1 was overexpressed in CHX-interfered SW480 cells to explore the influence of β-TrCP on TFAP4 expression.The overexpression or knockdown of β-TrCP in co-immunoprecipitation(Co-IP)experiments did not change the level of TFAP4 because it affected other signaling pathways.The E(135)on TFAP4 was mutated to A,and the S(139)was mutated to A,and then transfected TFAP4 with mutated domain in SW480 cells treated with CHX to detect the changes in TFAP4half-life time and ubiquitination level.CK1/CK2/GSK3 phosphorylated key enzyme in-hibitors were used to intervene SW480 cells,Western blot assay was used to detect TFAP4 levels,and then the influence of CK2 inhibitors on TFAP4 ubiquitination level was detected.Cell migration performance was analyzed by scratch assay,and cell invasion ability was ana-lyzed by Transwell assay.Results TFAP4 increased in a dose-dependent manner with the concentration change of MLN4924 treatment.MLN4924 treatment could significantly prolong the half-life time of endogenous TFAP4 protein.There was an interaction between TFAP4 and CK2,CK2 inhibitor could reduce the ubiquitination level of TFAP4 and significantly prolong the half-life time of the protein.The knockdown of β-TrCP significantly inhibited the degradation of TFAP4.β-TrCP directly interacted with TFAP4 and promoted its ubiq-uitination.The mutation of E135A and S139A in TFAP4 prolonged its half-life time,and the silencing of β-TrCP promoted cell prolif-eration and migration.Conclusion SCFβ-TrCP may degrade TFAP4 through ubiquitination modification,thereby inhibiting the occurrence of colorectal epithelial-mesenchymal transformation,and then inhibiting tumor invasion and metastasis,which may provide a new idea for the treatment of colorectal cancer.

SCFβ-TrCPUbiquitinationTFAP4Colorectal cancerEpithelial-mesenchymal transition

厉金雷、吴祥斌、蔡剑辉

展开 >

325000 温州医科大学附属第一医院结直肠肛门外科

SCFβ-TrCP 泛素化 TFAP4 结直肠癌 上皮间质转化

浙江省温州市科技局项目

Y20210932

2024

医学研究杂志
中国医学科学院

医学研究杂志

CSTPCD
影响因子:0.702
ISSN:1673-548X
年,卷(期):2024.53(4)
  • 24